Morgana L Mongraw-Chaffin1, Cheryl A M Anderson, Matthew A Allison, Pamela Ouyang, Moyses Szklo, Dhananjay Vaidya, Mark Woodward, Sherita Hill Golden. 1. Department of Family and Preventive Medicine (M.L.M.-C., C.A.M.A., M.A.A.), School of Medicine, University of California San Diego, San Diego California 92093; Department of Epidemiology (M.L.M.-C., C.A.M.A., M.S., M.W., S.H.G.), Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205; Department of Medicine (P.O., D.V., S.H.G.), The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; The George Institute for Global Health (M.W.), The University of Sydney, Sydney, New South Wales, Australia 2000; and The George Institute for Global Health (M.W.), Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, United Kingdom.
Abstract
CONTEXT: Sex hormones may influence adipose tissue deposition, possibly contributing to sex disparities in cardiovascular disease risk. OBJECTIVE: We hypothesized that associations of sex hormone levels with visceral and subcutaneous fat differ by sex. DESIGN, SETTING, AND PARTICIPANTS: Participants were from the Multi-Ethnic Study of Atherosclerosis with sex hormone levels at baseline and visceral and subcutaneous fat measurements from computed tomography at visit 2 or 3 (n = 1835). MAIN OUTCOME MEASURES: Multivariable linear regression was used to investigate the relationships between sex hormones and adiposity. Testing for interaction by sex, race/ethnicity, and age was conducted. RESULTS: In adjusted models, there was a modest significant positive association between estradiol and visceral fat in both sexes (percent difference in visceral fat for 1% difference in hormone [95% confidence interval] in women, 5.44 [1.82, 9.09]; and in men, 8.22 [0.61, 16.18]). Higher bioavailable T was significantly associated with higher visceral and subcutaneous fat in women and with the reverse in men (women, 14.38 [10.23, 18.69]; men, -7.69 [-13.06, -1.00]). Higher dehydroepiandrosterone was associated with higher visceral fat in women (7.57 [1.71, 13.88]), but not in men (-2.47 [-8.88, 4.29]). Higher SHBG was associated with significantly lower levels of adiposity in both sexes (women, -24.42 [-28.11, -20.55]; men, -27.39 [-32.97, -21.34]). There was no significant interaction by race/ethnicity or age. CONCLUSION: Sex hormones are significantly associated with adiposity, and the associations of androgens differ qualitatively by sex. This heterogeneity may help explain the complexity of the contribution of sex hormones to sex differences in cardiovascular disease.
CONTEXT: Sex hormones may influence adipose tissue deposition, possibly contributing to sex disparities in cardiovascular disease risk. OBJECTIVE: We hypothesized that associations of sex hormone levels with visceral and subcutaneous fat differ by sex. DESIGN, SETTING, AND PARTICIPANTS: Participants were from the Multi-Ethnic Study of Atherosclerosis with sex hormone levels at baseline and visceral and subcutaneous fat measurements from computed tomography at visit 2 or 3 (n = 1835). MAIN OUTCOME MEASURES: Multivariable linear regression was used to investigate the relationships between sex hormones and adiposity. Testing for interaction by sex, race/ethnicity, and age was conducted. RESULTS: In adjusted models, there was a modest significant positive association between estradiol and visceral fat in both sexes (percent difference in visceral fat for 1% difference in hormone [95% confidence interval] in women, 5.44 [1.82, 9.09]; and in men, 8.22 [0.61, 16.18]). Higher bioavailable T was significantly associated with higher visceral and subcutaneous fat in women and with the reverse in men (women, 14.38 [10.23, 18.69]; men, -7.69 [-13.06, -1.00]). Higher dehydroepiandrosterone was associated with higher visceral fat in women (7.57 [1.71, 13.88]), but not in men (-2.47 [-8.88, 4.29]). Higher SHBG was associated with significantly lower levels of adiposity in both sexes (women, -24.42 [-28.11, -20.55]; men, -27.39 [-32.97, -21.34]). There was no significant interaction by race/ethnicity or age. CONCLUSION: Sex hormones are significantly associated with adiposity, and the associations of androgens differ qualitatively by sex. This heterogeneity may help explain the complexity of the contribution of sex hormones to sex differences in cardiovascular disease.
Authors: Joel S Finkelstein; Hang Lee; Sherri-Ann M Burnett-Bowie; J Carl Pallais; Elaine W Yu; Lawrence F Borges; Brent F Jones; Christopher V Barry; Kendra E Wulczyn; Bijoy J Thomas; Benjamin Z Leder Journal: N Engl J Med Date: 2013-09-12 Impact factor: 91.245
Authors: Sandeep Dhindsa; Michael G Miller; Cecilia L McWhirter; Donald E Mager; Husam Ghanim; Ajay Chaudhuri; Paresh Dandona Journal: Diabetes Care Date: 2010-03-03 Impact factor: 19.112
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Hui Zhou; Yuesong Wang; Matthew Gatcombe; Jacob Farris; Julianne C Botelho; Samuel P Caudill; Hubert W Vesper Journal: Anal Bioanal Chem Date: 2017-08-11 Impact factor: 4.142
Authors: Nancy Swords Jenny; Nels C Olson; Matthew A Allison; Dena E Rifkin; Lori B Daniels; Ian H de Boer; Christina L Wassel; Russell P Tracy Journal: Glob Heart Date: 2016-09
Authors: Catherine Kim; Dana Dabelea; Rita R Kalyani; Costas A Christophi; George A Bray; Xavier Pi-Sunyer; Christine H Darwin; Swaytha Yalamanchi; Elizabeth Barrett-Connor; Sherita Hill Golden; Edward J Boyko Journal: J Clin Endocrinol Metab Date: 2017-09-01 Impact factor: 5.958
Authors: Veronica Wendy Setiawan; Unhee Lim; Loren Lipworth; Shelly C Lu; John Shepherd; Thomas Ernst; Lynne R Wilkens; Brian E Henderson; Loïc Le Marchand Journal: Clin Gastroenterol Hepatol Date: 2015-09-25 Impact factor: 11.382
Authors: Wesley T O'Neal; Saman Nazarian; Alvaro Alonso; Susan R Heckbert; Viola Vaccarino; Elsayed Z Soliman Journal: Endocrine Date: 2017-08-07 Impact factor: 3.633
Authors: Gertraud Maskarinec; Michelle Ciba; Dan Ju; John A Shepherd; Thomas Ernst; Anna H Wu; Kristine R Monroe; Unhee Lim; Lynne R Wilkens; Loïc Le Marchand Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-11-14 Impact factor: 4.090